Communiqués Conavi Medical Corp. OTC Markets

Actions

CNVIF

CA2059531020

Equipement et technologie médicale avancés

Marché Fermé - OTC Markets 18:35:14 18/09/2026			Varia. 5j.	Varia. 1 janv.
0,1149 ^USD	+0,90%		-4,49%	-65,23%

17/09	Conavi Medical Corp. annonce des changements au sein de sa direction	CI
17/09	Conavi Medical Corp. annonce la publication d'un rapport de cas examiné par des pairs soulignant l'utilité clinique de l'imagerie hybride IVUS-OCT	CI

Communiqués

17/09	Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team	AQ
07/09	Conavi Medical Announces Media and Digital Marketing Agreements	AQ
05/09	Conavi Medical Announces Media and Digital Marketing Agreements	GL
27/08	Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights	AQ
08/07	Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging	AQ
29/06	Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund	AQ
28/05	Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights	AQ
11/05	Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants	GL
23/04	Conavi Medical : Corporate Presentation (conavi medical presentation april update v3a491cba3da0)	PU
23/04	Conavi Medical : Corporate Presentation (conavi medical presentation april update v25f306fe3e46)	PU
23/04	Conavi Medical Awarded 2026 TAG Innovation Award	AQ
21/04	Conavi Medical : Corporate Presentation (conavi medical presentation april update v10fca7b352bf)	PU
20/04	Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging	GL
14/04	Conavi Medical : Corporate Presentation (conavi medical presentation march update v238a4ddfd618)	PU
09/04	Conavi Medical to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference	NE
02/04	Conavi Medical Announces Results from Its Annual General Meeting of Shareholders	GL
26/02	Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights	GL
13/02	Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging	GL
13/01	Conavi Medical Corp. Announces Closing of $12M Public Offering	GL
08/01	Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus	GL
29/12	Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights	GL
18/12	Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants	GL
24/11	Conavi Medical : Corporate Presentation (conavi medical presentation november 21 20259fa33a56b17)	PU
21/11	Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants	GL
03/11	Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization	GL